Editorial
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. May 15, 2024; 16(5): 1683-1689
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.1683
Figure 2
Full Size Figure Download Figure
Figure 2 The "map" of disparities: global numerical representation of patients’ percentage undergoing colorectal cancer screening. United States-North America 54.7%; Northern Europe (Nordic countries, Poland, Romania) 46%; Southern Europe 34%; Western Asia 22%; China-Japan 42%; India 1,8%; Sub-Saharian Africa 0.7%; (patients submitted to colonoscopy faecal immunochemical test, fecal occult blood test from 2021-2023).